{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T03:58:21Z","timestamp":1768017501898,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1999,8,1]],"date-time":"1999-08-01T00:00:00Z","timestamp":933465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1999,8,1]],"date-time":"1999-08-01T00:00:00Z","timestamp":933465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[1999,8]]},"DOI":"10.1016\/s0002-9343(99)00007-8","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T20:40:36Z","timestamp":1027629636000},"page":"2-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"special_numbering":"S2","title":["Diabetic neuropathy: scope of the syndrome"],"prefix":"10.1016","volume":"107","author":[{"given":"Douglas A","family":"Greene","sequence":"first","affiliation":[]},{"given":"Martin J","family":"Stevens","sequence":"additional","affiliation":[]},{"given":"Eva L","family":"Feldman","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0002-9343(99)00007-8_BIB1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2337\/diacare.1.3.168","article-title":"Diabetes mellitus and its degenerative complications","volume":"1","author":"Pirart","year":"1978","journal-title":"Diabetes Care"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB2","series-title":"Peripheral Neuropathy","first-page":"1219","article-title":"Diabetic and hypoglycemic neuropathy","author":"Thomas","year":"1993"},{"issue":"suppl 2","key":"10.1016\/S0002-9343(99)00007-8_BIB3","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.2337\/diab.46.2.S54","article-title":"Classification, differential diagnosis, and staging of diabetic peripheral neuropathy","volume":"46","author":"Thomas","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB4","first-page":"154","article-title":"Metabolic neuropathy","volume":"7","author":"Thomas","year":"1973","journal-title":"J R Coll Physicians Lond"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev.me.41.020190.001511","article-title":"Diabetic neuropathy","volume":"41","author":"Greene","year":"1990","journal-title":"Annu Rev Med"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB6","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nm0696-703","article-title":"The role of endogenous nerve growth factor in human diabetic neuropathy","volume":"2","author":"Anand","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB7","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/pgmj.59.695.556","article-title":"The natural history of painful diabetic neuropathy\u2014a 4-year study","volume":"59","author":"Boulton","year":"1983","journal-title":"Postgrad Med J"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB8","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/jnnp.46.6.491","article-title":"The natural history of acute painful neuropathy in diabetes mellitus","volume":"46","author":"Archer","year":"1983","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0733-8619(05)70334-0","article-title":"Diabetic neuropathy","volume":"15","author":"Pourmand","year":"1997","journal-title":"Neurol Clin"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB10","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ana.410250305","article-title":"Diabetic truncal neuropathy","volume":"25","author":"Stewart","year":"1989","journal-title":"Ann Neurol"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB11","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/BF00252626","article-title":"Prevalence of diabetic autonomic neuropathy measured by simple bedside tests","volume":"20","author":"Dyrberg","year":"1981","journal-title":"Diabetologia"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1464-5491.1986.tb00708.x","article-title":"Autonomic neuropathy and diabetic foot ulceration","volume":"3","author":"Edmonds","year":"1986","journal-title":"Diabetic Med"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB13","first-page":"635","article-title":"Progression of diabetic autonomic neuropathy over a decade in insulin-dependent diabetics","volume":"75","author":"Sampson","year":"1990","journal-title":"Q J Med"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB14","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0735-1097(98)00128-4","article-title":"Scintigraphic assessment of regionalized defects in myocardial sympathetic innervation and blood flow regulation in diabetic patients with autonomic neuropathy","volume":"31","author":"Stevens","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB15","first-page":"365","article-title":"Pathogenesis of diabetic neuropathy","volume":"4","author":"Feldman","year":"1997","journal-title":"Clin Neurosci"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB16","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1464-5491.1995.tb00544.x","article-title":"The aetiology of diabetic neuropathy","volume":"12","author":"Stevens","year":"1995","journal-title":"Diabet Med"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB17","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB18","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/ana.410380607","article-title":"Effect of intensive diabetes treatment on nerve conduction in the diabetes control and complications trial","volume":"38","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB19","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1126\/science.7112124","article-title":"Living with water stress","volume":"217","author":"Yancey","year":"1982","journal-title":"Science"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1172\/JCI113366","article-title":"Sorbitol, osmoregulation, and the complications of diabetes","volume":"81","author":"Burg","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB21","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1172\/JCI116629","article-title":"Altered aldose reductase gene regulation in cultured human retinal pigment epithelial cells","volume":"92","author":"Henry","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB22","doi-asserted-by":"crossref","first-page":"C964","DOI":"10.1152\/ajpcell.1989.257.5.C964","article-title":"Osmoregulatory fluxes of myo-inositol and betaine in renal cells","volume":"257","author":"Nakanishi","year":"1989","journal-title":"Am J Physiol"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB23","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/BF00404069","article-title":"Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat","volume":"36","author":"Stevens","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB24","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1172\/JCI111030","article-title":"Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation","volume":"72","author":"Greene","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB25","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.2337\/diacare.15.12.1902","article-title":"Complications","volume":"15","author":"Greene","year":"1992","journal-title":"Diabetes Care"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB26","first-page":"A537","article-title":"Attenuation of nerve vascular and functional deficits by nerve taurine replacement in the streptozotocin-diabetic rat","volume":"47","author":"Pop-Busui","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/dmr.5610090304","article-title":"Aldose reductase inhibitors","volume":"9","author":"Greene","year":"1993","journal-title":"Diabetes Metab Rev"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB28","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1212\/WNL.53.3.580","article-title":"Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy","volume":"53","author":"Greene","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB29","series-title":"Diabetic Neuropathy","first-page":"266","article-title":"Nerve microenvironment in diabetic neuropathy","author":"Low","year":"1987"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB30","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.410190503","article-title":"Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy","volume":"19","author":"Dyck","year":"1986","journal-title":"Ann Neurol"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB31","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1007\/BF00400804","article-title":"Impaired blood flow and arterio-venous shunting in human diabetic neuropathy","volume":"36","author":"Tesfaye","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB32","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/brain\/120.7.1131","article-title":"Local human sural nerve blood flow in diabetic and other polyneuropathies","volume":"120","author":"Theriault","year":"1997","journal-title":"Brain"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB33","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.2337\/diacare.18.8.1160","article-title":"Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy","volume":"18","author":"Nagamatsu","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB34","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1042\/bj2560205","article-title":"Hydroxyl radical production and autoxidative glycosylation","volume":"256","author":"Hunt","year":"1988","journal-title":"Biochem J"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB35","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1042\/bj2910529","article-title":"Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation","volume":"291","author":"Hunt","year":"1993","journal-title":"Biochem J"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1006\/abbi.1995.1220","article-title":"Metabolism of fructose-3-phosphate in the diabetic rat lens","volume":"318","author":"Lal","year":"1995","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB37","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s001250050131","article-title":"Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats","volume":"37","author":"Cameron","year":"1994","journal-title":"Diabetologia"},{"issue":"suppl 2","key":"10.1016\/S0002-9343(99)00007-8_BIB38","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.2337\/diab.46.2.S38","article-title":"The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy","volume":"46","author":"Low","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB39","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/BF00400603","article-title":"Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid","volume":"38","author":"Ziegler","year":"1995","journal-title":"Diabetologia"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB40","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/jnr.490260217","article-title":"Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus","volume":"26","author":"Hellweg","year":"1990","journal-title":"J Neurosci Res"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB41","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1006\/exnr.1994.1181","article-title":"Axonal transport of endogenous nerve growth factor (NGF) and NGF receptor in experimental diabetic neuropathy","volume":"130","author":"Hellweg","year":"1994","journal-title":"Exp Neurol"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB42","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2337\/diab.30.10.797","article-title":"Retrograde axonal transport of transmitter enzymes, fucose-labeled protein, and nerve growth factor in streptozotocin-diabetic rats","volume":"30","author":"Jakobsen","year":"1981","journal-title":"Diabetes"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB43","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0166-2236(94)90169-4","article-title":"Diabetic neuropathy, nerve growth factor and other neurotrophic factors [see comments]","volume":"17","author":"Brewster","year":"1994","journal-title":"Trends Neurosci"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0006-8993(94)90252-6","article-title":"Nerve growth factor administration protects against experimental diabetic sensory neuropathy","volume":"634","author":"Apfel","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB45","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1212\/WNL.51.3.695","article-title":"Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy","volume":"51","author":"Apfel","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB46","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/978-1-4757-9551-6_13","article-title":"Nerve growth factor and oxidative stress in the nervous system","volume":"429","author":"Pan","year":"1997","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB47","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0006-8993(95)01513-2","article-title":"NGF, BDNF and NT-5, but not NT-3 protect against MPP+toxicity and oxidative stress in neonatal animals","volume":"713","author":"Kirschner","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB48","first-page":"55","article-title":"Oxidative stress, age-related neurodegeneration, and the potential for neurotrophic treatment","volume":"7","author":"Williams","year":"1995","journal-title":"Cerebrovasc Brain Metab Rev"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB49","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3940(97)13383-3","article-title":"Alpha-lipoic acid corrects neuropeptide deficits in diabetic rats via induction of trophic support","volume":"222","author":"Garrett","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1016\/S0002-9343(99)00007-8_BIB50","unstructured":"Levin ME, O\u2019Neal LW, Bowker J, eds. The Diabetic Foot, 4th ed. St. Louis, MO: CV Mosby, 1988;33."}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934399000078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934399000078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T08:12:24Z","timestamp":1757578344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934399000078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,8]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,8]]}},"alternative-id":["S0002934399000078"],"URL":"https:\/\/doi.org\/10.1016\/s0002-9343(99)00007-8","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[1999,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetic neuropathy: scope of the syndrome","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0002-9343(99)00007-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1999 Excerpta Medica Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}